...
首页> 外文期刊>Anesthesia and Analgesia: Journal of the International Anesthesia Research Society >Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats.
【24h】

Repinotan, a selective 5-HT1A-R-agonist, antagonizes morphine-induced ventilatory depression in anesthetized rats.

机译:选择性5-HT1A-R激动剂Repinotan拮抗吗啡诱导的麻醉大鼠的通气抑制。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Spontaneous breathing during mechanical ventilation improves arterial oxygenation and cardiovascular function, but is depressed by opioids during critical care. Opioid-induced ventilatory depression was shown to be counteracted in anesthetized rats by serotonin(1A)-receptor (5-HT(1A)-R)-agonist 8-OH-DPAT, which cannot be applied to humans. Repinotan hydrochloride is a selective 5-HT(1A)-R-agonist already investigated in humans, but the effects on ventilation and nociception are unknown. In this study, we sought to establish (a) the effects of repinotan on spontaneous breathing and nociception, and (b) the interaction with the standard opiate morphine. METHODS: The dose-dependent effects of repinotan, given alone or in combination with morphine, on spontaneous minute ventilation (MV) and nociceptive tail-flick reflex latencies (TFLs) were measured simultaneously in spontaneously breathing anesthetized rats. An additional series with NaCl 0.9% and the 5-HT(1A)-R-antagonist WAY 100 135 served as controls. RESULTS: (a) Repinotan dose-dependently activated spontaneous breathing (MV, mean [95% confidence interval]; 53% [29%-77%]) of pretreatment level) and suppressed nociception (TLF, 91% maximum possible effect [68%-114%]) with higher doses of repinotan (2-200 mug/kg). On the contrary, nociception was enhanced with a small dose of repinotan (0.2 mug/kg; TFL, -47% maximum possible effect [-95% to 2%]). Effects were prevented by 5-HT(1A)-antagonist WAY 100 135. (B) Morphine-induced depression of ventilation (MV, -72% [-100% to -44%]) was reversed by repinotan (20 mug/kg), which returned spontaneous ventilation to pretreatment levels (MV, 18% [-40% to 77%]). The morphine-induced complete depression of nociception was sustained throughout repinotan and NaCl 0.9% administration. Despite a mild decrease in mean arterial blood pressure, there were no serious cardiovascular side effects from repinotan. CONCLUSIONS: The 5-HT(1A)-R-agonist repinotan activates spontaneous breathing in anesthetized rats even in morphine-induced ventilatory depression. The potency of 5-HT(1A)-R-agonists to stimulate spontaneous breathing and their antinociceptive effects should be researched further.
机译:背景:机械通气期间的自发呼吸改善了动脉氧合和心血管功能,但在重症监护期间被阿片类药物抑制。阿片类药物引起的通气抑制在被麻醉的大鼠中被5-羟色胺(1A)-受体(5-HT(1A)-R)-激动剂8-OH-DPAT抵消,该物质不能应用于人类。盐酸Repinotan是一种选择性5-HT(1A)-R-激动剂,已在人体中进行了研究,但对通气和伤害感受的影响尚不清楚。在这项研究中,我们试图确定(a)repinotan对自发呼吸和伤害感受的影响,以及(b)与标准鸦片吗啡的相互作用。方法:在自发呼吸的麻醉大鼠中,同时测量了雷诺坦单独或与吗啡联合给予对自发性分钟通气(MV)和伤害性甩尾反射潜伏期(TFL)的剂量依赖性。含有0.9%NaCl和5-HT(1A)-R拮抗剂WAY 100 135的其他系列作为对照。结果:(a)Repinotan剂量依赖性地激活自发呼吸(MV,治疗前平均水平[95%置信区间]; 53%[29%-77%])并抑制伤害感受(TLF,最大可能效应91%)[68] %-114%]),并使用较高剂量的repinotan(2-200杯/千克)。相反,小剂量的雷诺坦(0.2杯/千克; TFL,最大可能作用-47%[-95%至2%])可增强伤害感受。 5-HT(1A)-拮抗剂WAY 100135可防止这种作用。(B)吗啡(20杯/千克)可逆转吗啡引起的通气抑制(MV,-72%[-100%至-44%]) ),使自发通气恢复到预处理水平(MV,18%[-40%至77%])。吗啡和0.9%NaCl的整个给药过程中都持续发生吗啡诱导的痛觉下降。尽管平均动脉血压轻度下降,但雷匹坦并没有严重的心血管副作用。结论:5-HT(1A)-R激动剂维甲酸可以激活麻醉大鼠的自发呼吸,即使在吗啡引起的通气抑制中也是如此。 5-HT(1A)-R激动剂刺激自发性呼吸的功效及其抗伤害作用应进一步研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号